considerations for the vaccine trial program
New ethical considerations in vaccine trials
... a trial subject suffers an emergency when in the vicinity of a trial team, everything pos- sible should be done to ...the trial itself is attempted on too ambitious a scale it can have adverse conse- ...
5
COVID-19 Vaccine Safety Considerations
... (DTP) vaccine, although protective against the three target diseases, increases female mortality from other infectious diseases ...DTP vaccine administered after the measles vaccine was the ...
46
Ethical considerations in HIV preventive vaccine research
... lengthy trial involving intensely intimate matters, involving repeated HIV testing, and involving exposure to culturally different scientific and medical concepts may cause anxiety, stress, depression, as well as ...
52
The aftermath of the Merck's HIV vaccine trial
... concept" vaccine trials have shown no protection from HIV-1 infection in the vaccinated group compared with a control group vaccinated with ...candidate vaccine. The vaccine formulation was expected ...
6
Human Papillomavirus Vaccine Program
... the vaccine non-compliance issue and vaccine parental refusal in the pediatric primary care ...polio vaccine and its risks for public ...guide vaccine programs to work toward increasing ...
68
Phylogenetic Considerations in Designing a Broadly Protective Multimeric L2 Vaccine
... AS04-adjuvanted vaccine against cervical infection and precancer caused by nonvaccine oncogenic HPV types: 4-year end- of-study analysis of the randomised, double-blind PATRICIA ...
10
Equitable vaccine distribution: context, considerations, implementation. March 2021
... COVID-19 vaccine landscape remains highly fluid, and it is your responsibility to ensure that decisions are made based on the most up-to-date information ...
25
Effective Messages in Vaccine Promotion: A Randomized Trial
... Finally, these results suggest several avenues for future research. First, why did the narrative we tested increase beliefs in MMR side effects? Subtle narratives have been found to be per- suasive because individuals “ ...
10
Practical Considerations for Adaptive Trial Design and Implementation
... ADAPTIVE TRIAL IMPLEMENTATION Our example illustrates that implementing an adaptive design does require careful planning and creates an operational overhead which adds to the overall costs of the trial ...
16
Analysis of HLA A*02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial
... in vaccine recipients expressing ...the trial overall, were a significant correlate in participants without ...of vaccine-in- duced antibodies to a subtype B peptide that encompasses site 169 and the ...
14
Estimation of the efficacy of seasonal influenza vaccine : vaccine development, statistical modelling and trial design
... Second, the intermediate and final objectives to achieve should be clearly defined. As the product development advances and depending on the state of the market for the product, objectives should be re-evaluated. ...
147
The National Vaccine Injury Compensation Program
... Childhood Vaccine Injury Act of 1986 established the Na- tional Vaccine Injury Compensation Program to compensate people thought to be injured by certain ...stabilize vaccine costs, and to es- ...
6
The ecall Program: Overview and Design Considerations
... ETSI TS 126 267; TSG services and system aspects; eCall data transfer – in-band modem solution; general description This document specifies the eCall In-band Modem, which is used for r[r] ...
13
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines
... contemporary vaccine research for the treatment of viral, bacterial, fungal and parasitic ...future vaccine development due to their enhanced interaction with the negatively charged immune ...diverse ...
23
RECOMMENDATIONS FOR PRODUCTION AND CONTROL OF INFLUENZA VACCINE (INACTIVATED) Introduction General considerations
... Although the technology is still under development, use of reverse genetics for vaccine virus development is likely to affect interpandemic and pandemic vaccines alike. This technology involves transfecting ...
66
Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi arm phase I/II trial design
... at trial end is based on a single-stage Fleming design per arm, comparing the observed proportion of responders in an immunogenicity screening assay to an unacceptably low proportion, without direct comparisons ...
12
Simian immunodeficiency virus DNA vaccine trial in macaques.
... incidence of AIDS during the first year of infection. MATERIALS AND METHODS Vaccine DNAs. The pSIV239.dpol vaccine DNA was created by cloning the SIV239.dpol insert into the pBC12/CMV expression vector. ...
14
Validation of nested Bordetella PCR in pertussis vaccine trial
... MATERIALS AND METHODS Clinical material and case definition. A total of 9,829 children born during 1992 were enrolled in a phase 3 pertussis vaccine efficacy trial which took place from 1992 to 1995 in ...
6
Strategies for Improving Vaccine Delivery: A Cluster-Randomized Trial
... effectiveness trial comparing financial incentives to a virtual learning collaborative for impact on immunization ...A trial examining immunization coverage among children with Medicaid insurance found no ...
11
Safety and Immunogenicity of a Recombinant Influenza Vaccine: A Randomized Trial
... the trial, and wrote the first draft of the manuscript; Dr Izikson selected the investigative sites, managed the operational aspects of study conduct, and reviewed the manuscript, subjecting it to careful quality ...
10